TGFbeta targeted antibodies (Novartis)

N/A

Report date: 2025/01/26 17:33:38

Base Information

Drug NameTGFbeta targeted antibodies (Novartis)

Drug Alias NameTGFbeta targeted antibody (XOMA)anti-TGF beta-1/2 (XOMA)TGFbeta targeted antibodies (XOMA)Transforming growth factor beta targeted antibody (XOMA)ABC-3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionTransforming growth factor beta 1 modulatorsTransforming growth factor beta 2 modulators

TargetsTransforming growth factor beta 2Transforming growth factor beta 1

Therapy Area/IndicationsSolid tumoursFibrosisBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesXoma Corp

China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag Xoma Corp

Inactive CompaniesN/A

Active IndicationsSolid tumoursFibrosisBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A